慢性疾病与转化医学(英文)(Chronic Diseases and Translational Medicine)(不收版面费审稿费)(可网站投稿)

《慢性疾病与转化医学(英文)》(Chronic Diseases and Translational Medicine)(季刊),杂志于2015年创办,经新闻出版总署批准的正规刊物,由中国科学技术协会主管,中华医学会主办的全球第一本致力于慢病防控的英文期刊。主要报道心血管、肿瘤、呼吸、内分泌、肾脏、消化等慢性疾病及相关转化医学方面的研究。栏目: Editorial,Review, Perspective, Meta Analysis, Protocol,Original Article, Comments, Correspondence。

本刊特点:CSCD核心期刊(2025-2026), 科技核心期刊(2024自然科学),目次收录(维普),目次收录(万方),目次收录(知网),微信公号信息不收版面费,外文期刊,第二批认定学术期刊,

慢性疾病与转化医学(英文)(Chronic Diseases and Translational Medicine)

期刊基本信息

出版周期:季刊 级别:核心期刊
主管部门:中国科学技术协会
主办单位:中华医学会
编辑部:《慢性疾病与转化医学(英文)》编辑部
中国国内刊号:CN10-1249/R
国际标准刊号:ISSN 2095-882X
价格:40元/期
知网复合影响因子:0.889
知网综合影响因子:0.593

杂志社联系方式

地址:北京市西城区东河沿街69号《慢性疾病与转化医学(英文)》编辑部
邮编:100052
电话:010-51322279
官网微信公众号:慢性疾病与转化医学(cdtm2015)
官网邮箱:cdtm@cmaph.org
官方网站:https://onlinelibrary.wiley.com/journal/25890514

杂志征稿投稿要求

Author Guidelines投稿指南

【杂志社官方网站信息】

Author Guidelines

Note: Chronic Diseases and Translational Medicine transfers to Wiley from January 2022. For the five articles in the transition stage (Early view published by the previous publisher and later compiled in issues by Wiley), the format may not comply to the following guideline. After the transition stage, all articles will follow the requirements displayed at the Author Guideline page.

Sections

1. Submission

2. Aims and Scope

3. Manuscript Categories and Requirements

4. Preparing the Submission

5. Editorial Policies and Ethical Considerations

6. Author Licensing

7. Publication Process After Acceptance

8. Post Publication

9. Editorial Office Contact Details

1. SUBMISSION

Thank you for your interest in Chronic Diseases and Translational Medicine. Note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.

Free Format submission

Chronic Diseases and Translational Medicine now offers Free Format submission for a simplified and streamlined submission process.

Cover letter

A cover letter should be included in the ‘Cover Letter Field’ of the ScholarOne system. The text can be entered directly into the field or uploaded as a file.

The cover letter must contain:

i) A statement confirming the paper has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium;

ii) An acknowledgment that all authors have contributed significantly and in keeping with the latest guidelines of the International Committee of Medical Journal Editors, each author’s contribution to the paper is to be described, i.e., what role each author participated in;

iii) a statement confirming that all authors are in agreement with the content of the manuscript.

Submission

Once you have prepared your submission in accordance with the Guidelines, manuscripts should be submitted online at https://mc.manuscriptcentral.com/cdtm

We look forward to your submission.

2. AIMS AND SCOPE

Chronic diseases have become a major challenge to human health globally. The aim of Chronic Diseases and Translational Medicine is to promote the prevention, diagnosis and treatment of chronic diseases by providing a forum for communicating the latest research advances from preclinical, translational, and clinical researchers from all established and emerging disciplines relevant to chronic diseases.

……

更多详情:

https://onlinelibrary.wiley.com/page/journal/25890514/homepage/author-guidelines

刊知网 精心整理,转载请注明出处:https://www.kanzhiwang.com/archives/14288

我要点评 请您把投稿经验分享出来 让大家少走弯路少踩坑,我为人人、人人为我。

内容纠错 杂志信息如有错漏 请在下方留言。

上一篇 2024年12月14日 下午8:01
下一篇 2024年12月14日 下午8:10

相关推荐

发表回复

登录后才能评论

联系我们

191 1833 1195

QQ:321628655
邮件:321628655@qq.com

工作时间:周一至周五,9:30-18:30,节假日休息